1,918
Views
16
CrossRef citations to date
0
Altmetric
Oncology

Hsa_circ_0042823 accelerates cancer progression via miR-877-5p/FOXM1 axis in laryngeal squamous cell carcinoma

, , , , , & show all
Pages 961-971 | Received 05 Mar 2021, Accepted 20 May 2021, Published online: 14 Jun 2021

References

  • Agnello F, Cupido F, Sparacia G, et al. Computerised tomography and magnetic resonance imaging of laryngeal squamous cell carcinoma: a practical approach. Neuroradiol J. 2017;30(3):197–204.
  • Obid R, Redlich M, Tomeh C. The treatment of laryngeal cancer. Oral Maxillofac Surg Clin North Am. 2019;31(1):1–11.
  • Kos A, Dijkema R, Arnberg A, et al. The hepatitis delta (delta) virus possesses a circular RNA. Nature. 1986;323(6088):558–560.
  • Jeck W, Sharpless N. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461.
  • Liu J, Li D, Luo H, et al. Circular RNAs: the star molecules in cancer. Mol Aspects Med. 2019;70:141–152.
  • Fan Y, Xia X, Zhu Y, et al. Circular RNA expression profile in laryngeal squamous cell carcinoma revealed by microarray. Cell Physiol Biochem. 2018;50(1):342–352.
  • Zhang J, Hu H, Zhao Y, et al. CDR1as is overexpressed in laryngeal squamous cell carcinoma to promote the tumour's progression via miR-7 signals. Cell Prolif. 2018;51(6):e12521.
  • Wang JX, Liu Y, Jia XJ, et al. Upregulation of circFLNA contributes to laryngeal squamous cell carcinoma migration by circFLNA-miR-486-3p-FLNA axis. Cancer Cell Int. 2019;19:196.
  • Wei Z, Chang K, Fan C. Hsa_circ_0042666 inhibits proliferation and invasion via regulating miR-223/TGFBR3 axis in laryngeal squamous cell carcinoma. Biomed Pharmacother. 2019;119:109365.
  • Xuan LJ, Qu LM, Zhou H, et al. Circular RNA: a novel biomarker for progressive laryngeal cancer. Am J Transl Res. 2016;8(2):932–939.
  • Yan TH, Qiu C, Sun J, et al. MiR-877-5p suppresses cell growth, migration and invasion by targeting cyclin dependent kinase 14 and predicts prognosis in hepatocellular carcinoma. Eur Rev Med Pharmacol Sci. 2018;22(10):3038–3046.
  • Zhang L, Li C, Cao L, et al. microRNA-877 inhibits malignant progression of colorectal cancer by directly targeting MTDH and regulating the PTEN/Akt pathway. Cancer Manag Res. 2019;11:2769–2781.
  • Huang X, Qin J, Lu S. Up-regulation of miR-877 induced by paclitaxel inhibits hepatocellular carcinoma cell proliferation though targeting FOXM1. Int J Clin Exp Pathol. 2015;8(2):1515–1524.
  • Chen W, Yuan K, Tao ZZ, et al. Deletion of Forkhead Box M1 transcription factor reduces malignancy in laryngeal squamous carcinoma cells. Asian Pac J Cancer Prev. 2011;12(7):1785–1788.
  • Jiang L, Wu X, Wang P, et al. Targeting FoxM1 by thiostrepton inhibits growth and induces apoptosis of laryngeal squamous cell carcinoma. J Cancer Res Clin Oncol. 2015;141(6):971–981.
  • Wang X, Wu T, Wang P, et al. Circular RNA 103862 promotes proliferation and invasion of laryngeal squamous cell carcinoma cells through the miR-493-5p/GOLM1 axis. Front Oncol. 2020;10:1064.
  • Wu Y, Zhang Y, Zheng X, et al. Circular RNA circCORO1C promotes laryngeal squamous cell carcinoma progression by modulating the let-7c-5p/PBX3 axis. Mol Cancer. 2020;19(1):99.
  • Liang J, Zhang S, Wang W, et al. Long non-coding RNA DSCAM-AS1 contributes to the tumorigenesis of cervical cancer by targeting miR-877-5p/ATXN7L3 axis. Biosci Rep. 2020;40(1):BSR20192061.
  • Wang X, Liu L, Zhao W, et al. LncRNA SNHG16 promotes the progression of laryngeal squamous cell carcinoma by mediating miR-877-5p/FOXP4 axis. Onco Targets Ther. 2020;13:4569–4579.
  • Wu K, Yu Z, Tang Z, et al. miR-877-5p suppresses gastric cancer cell proliferation through targeting FOXM1. Onco Targets Ther. 2020;13:4731–4742.
  • Jiang LZ, Wang P, Deng B, et al. Overexpression of Forkhead Box M1 transcription factor and nuclear factor-κB in laryngeal squamous cell carcinoma: a potential indicator for poor prognosis. Hum Pathol. 2011;42(8):1185–1193.
  • Yungang W, Xiaoyu L, Pang T, et al. miR-370 targeted FoxM1 functions as a tumor suppressor in laryngeal squamous cell carcinoma (LSCC). Biomed Pharmacother. 2014;68(2):149–154.